These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 15964479

  • 1. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL.
    Vaccine; 2005 Jul 14; 23(32):4110-9. PubMed ID: 15964479
    [Abstract] [Full Text] [Related]

  • 2. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.
    Pediatr Infect Dis J; 2003 Oct 14; 22(10):904-14. PubMed ID: 14551492
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.
    Pediatrics; 2007 Jan 14; 119(1):e12-21. PubMed ID: 17200237
    [Abstract] [Full Text] [Related]

  • 4. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH, Pan XJ, Wang XL.
    Vaccine; 2008 Aug 18; 26(35):4608-16. PubMed ID: 18597903
    [Abstract] [Full Text] [Related]

  • 5. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ, Koff RS, Meyerhoff AS.
    Am J Gastroenterol; 2002 Feb 18; 97(2):427-34. PubMed ID: 11866283
    [Abstract] [Full Text] [Related]

  • 6. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ, Saab S, Meyerhoff AS.
    J Am Coll Health; 2003 May 18; 51(6):227-36. PubMed ID: 14510025
    [Abstract] [Full Text] [Related]

  • 7. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb 18; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 8. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP.
    Pediatrics; 2007 Jan 18; 119(1):e22-9. PubMed ID: 17200247
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
    Chapko MK, Yee HS, Monto A, Dominitz JA.
    Vaccine; 2010 Feb 17; 28(7):1726-31. PubMed ID: 20044051
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.
    Vaccine; 2012 Dec 14; 30(52):7489-97. PubMed ID: 23107593
    [Abstract] [Full Text] [Related]

  • 11. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 12. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.
    J Infect Dis; 2005 Nov 15; 192(10):1720-6. PubMed ID: 16235169
    [Abstract] [Full Text] [Related]

  • 13. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ, Rosenthal P, Meyerhoff AS.
    Vaccine; 2004 Mar 12; 22(9-10):1241-8. PubMed ID: 15003653
    [Abstract] [Full Text] [Related]

  • 14. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.
    Am J Gastroenterol; 2002 Mar 12; 97(3):721-8. PubMed ID: 11922569
    [Abstract] [Full Text] [Related]

  • 15. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.
    Vaccine; 2004 May 07; 22(15-16):1862-7. PubMed ID: 15121296
    [Abstract] [Full Text] [Related]

  • 16. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF, Chen TH.
    Vaccine; 2009 Nov 12; 27(48):6770-6. PubMed ID: 19735755
    [Abstract] [Full Text] [Related]

  • 17. Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.
    Quezada A, Baron-Papillon F, Coudeville L, Maggi L.
    Rev Panam Salud Publica; 2008 May 12; 23(5):303-12. PubMed ID: 18510790
    [Abstract] [Full Text] [Related]

  • 18. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan 12; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of hepatitis A vaccination for adults in Belgium.
    Luyten J, Van de Sande S, de Schrijver K, Van Damme P, Beutels P.
    Vaccine; 2012 Sep 14; 30(42):6070-80. PubMed ID: 22858555
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.
    Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL.
    Rev Panam Salud Publica; 2007 Jun 14; 21(6):345-56. PubMed ID: 17761046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.